The lion's share of foreign drugs undergoing clinical trials in Russia Bashny.Net

The Agency Synergy Research Group conducted an independent analysis of the prevalence of drugs in which there was an established fact of clinical trials 65% of all approved international regulators of medicines in Russia.





According to Synergy Research Group, 215 of all clinical drug trials, 139 in 2013 held in Russia, which twice exceeds the same indicator of 2009. The main customers of clinical trials in Russia are the European and American pharmaceutical companies.





More clinical trials is carried out and Russian pharmaceutical companies: in 2009, they conducted 191 research, and in 2013 – 325. All the tested drugs into the REGISTER of MEDICINES of RUSSIA ® radar ®. The increase is attributable to increased investments in the development of innovative drugs. According to the Minister of health of the Russian Federation Veronika Skvortsova, in 2012, Russia had issued 17 permits for clinical trials of innovative medicines of domestic production. The result is more and more preclinical studies and noted the rapid arrival of new drugs on the market.

 

Source: scienceblog.ru